We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+8.96%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$73.6B
AUM Growth
+$1.15B
(+1.6%)
Cap. Flow
-$3.6B
Cap. Flow
% of AUM
-4.89%
Top 10 Holdings %
Top 10 Hldgs %
20.8%
Holding
3,102
New
50
Increased
790
Reduced
2,114
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$38.7M |
| 2 |
International Flavors & Fragrances
IFF
|
+$27.4M |
| 3 |
Neurocrine Biosciences
NBIX
|
+$14.7M |
| 4 |
ConocoPhillips
COP
|
+$14.5M |
| 5 |
Royalty Pharma
RPRX
|
+$9.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$269M |
| 2 |
Microsoft
MSFT
|
+$172M |
| 3 |
Amazon
AMZN
|
+$114M |
| 4 |
Walt Disney
DIS
|
+$62.4M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$61.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.61% |
| 2 | Financials | 14.26% |
| 3 | Healthcare | 12.86% |
| 4 | Consumer Discretionary | 12.27% |
| 5 | Industrials | 9.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Verastem
VSTM
$610M
| $497K | ﹤0.01% |
16,770
-781
| -4% | -$21.9K |
|
|
NPKI
2502
NPK International
NPKI
$1.14B
| $497K | ﹤0.01% |
158,403
-7,217
| -4% | -$22.3K |
|
2503
Boston Omaha
BOC
$436M
| $496K | ﹤0.01% |
16,785
-805
| -5% | -$29.1K |
|
2504
NN Inc
NNBR
$311M
| $495K | ﹤0.01% |
70,079
-2,160
| -3% | -$14.7K |
|
2505
Regional Management Corp
RM
$303M
| $494K | ﹤0.01% |
14,257
-1,203
| -8% | -$39.2K |
|
2506
First Bancorp
FNLC
$399M
| $493K | ﹤0.01% |
16,890
-550
| -3% | -$14.8K |
|
2507
Napco Security Technologies
NSSC
$1.48B
| $491K | ﹤0.01% |
28,166
+500
| +2% | +$7.71K |
|
2508
Southern Missouri Bancorp
SMBC
$850M
| $491K | ﹤0.01% |
12,459
-365
| -3% | -$13.1K |
|
|
SGFY
2509
DELISTED
Signify Health, Inc.
SGFY
| $490K | ﹤0.01% |
+16,763
| New | +$519K |
|
2510
Select Water Solutions
WTTR
$2.61B
| $488K | ﹤0.01% |
97,971
-2,780
| -3% | -$16.2K |
|
2511
Viant Technology
DSP
$265M
| $487K | ﹤0.01% |
+9,206
| New | +$474K |
|
2512
Lifecore Biomedical
LFCR
$190M
| $486K | ﹤0.01% |
45,889
-100
| -0.2% | -$1.12K |
|
2513
Primis Financial Corp
FRST
$404M
| $485K | ﹤0.01% |
33,383
-360
| -1% | -$4.95K |
|
|
VTLE
2514
DELISTED
Vital Energy
VTLE
| $485K | ﹤0.01% |
16,141
+893
| +6% | +$27.4K |
|
2515
Cullinan Oncology
CGEM
$1.14B
| $483K | ﹤0.01% |
+11,584
| New | +$470K |
|
|
FLXN
2516
DELISTED
Flexion Therapeutics, Inc.
FLXN
| $482K | ﹤0.01% |
53,872
-6,170
| -10% | -$70.7K |
|
|
GNTY
2517
DELISTED
Guaranty Bancshares
GNTY
| $481K | ﹤0.01% |
13,085
-481
| -4% | -$15.3K |
|
|
NTST
2518
NETSTREIT Corp
NTST
$2.1B
| $477K | ﹤0.01% |
25,774
+8,698
| +51% | +$155K |
|
2519
Peoples Financial Services
PFIS
$707M
| $475K | ﹤0.01% |
11,249
-410
| -4% | -$16.9K |
|
2520
Citizens
CIA
$192M
| $472K | ﹤0.01% |
81,486
-3,098
| -4% | -$19.1K |
|
2521
CytomX Therapeutics
CTMX
$754M
| $471K | ﹤0.01% |
60,986
+1,845
| +3% | +$14.6K |
|
|
TECX
2522
Tectonic Therapeutic
TECX
$606M
| $470K | ﹤0.01% |
3,086
-79
| -2% | -$12.8K |
|
|
TACO
2523
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $470K | ﹤0.01% |
49,103
-1,700
| -3% | -$17.3K |
|
2524
Barnes & Noble Education
BNED
$443M
| $466K | ﹤0.01% |
572
+21
| +4% | +$14.4K |
|
|
DSSI
2525
DELISTED
Diamond S Shipping Inc. Common Shares
DSSI
| $466K | ﹤0.01% |
46,473
-1,177
| -2% | -$9.56K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2021 Portfolio in Review
As of Q1 2021, RhumbLine Advisers held 3,102 positions worth $73.6B, up 1.6% from $72.5B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
RhumbLine Advisers withdrew a net $3.6B in Q1 2021, closing 100 positions and reducing 2,114 holdings. Its most notable exit was Tiffany & Co., an estimated $26.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Financials and Healthcare.
Against the trend, RhumbLine Advisers opened a new position in NXP Semiconductors worth $42.7M.
- RhumbLine Advisers's largest Q1 2021 buy was NXP Semiconductors: 211,843 shares worth $42.7M.
- RhumbLine Advisers added most to International Flavors & Fragrances in Q1 2021, an estimated $27.4M increase.
- RhumbLine Advisers's biggest Q1 2021 reduction was Apple, cutting an estimated $269M.
- RhumbLine Advisers fully exited Tiffany & Co. in Q1 2021, selling an estimated $26.8M.
- RhumbLine Advisers's ten largest holdings make up 21% of its $73.6B portfolio in Q1 2021.
- RhumbLine Advisers opened 50 new positions and closed 100 in Q1 2021.
- RhumbLine Advisers's portfolio value rose 1.6% quarter-over-quarter to $73.6B.
Based on RhumbLine Advisers's 13F filing for Q1 2021, filed 6 May 2021.